# Lovastatin in Reducing Side Effects After Radiation Therapy in Women With Breast Cancer

> **NCT00902668** · PHASE2 · TERMINATED · sponsor: **Virginia Commonwealth University** · enrollment: 3 (actual)

## Conditions studied

- Breast Cancer
- Radiation Toxicity

## Interventions

- **DRUG:** lovastatin
- **OTHER:** questionnaire administration
- **PROCEDURE:** adjuvant therapy
- **RADIATION:** accelerated partial breast irradiation
- **RADIATION:** external beam radiation therapy

## Key facts

- **NCT ID:** NCT00902668
- **Lead sponsor:** Virginia Commonwealth University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-04
- **Primary completion:** 2011-04
- **Final completion:** 2013-04
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Slow accrual
- **Last updated:** 2013-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00902668

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00902668, "Lovastatin in Reducing Side Effects After Radiation Therapy in Women With Breast Cancer". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT00902668. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*